Using the cell-permeable, ErbB-specific inhibitor 4557W [24] we found that the proliferation at confluency of SMDF infected cells and cells dissociated from SMDF tumours was selectively blocked by the inhibitor in a dose-dependent manner (Figure 3B). The gene discussed is EGFR; the disease is neoplasm.